February 23, 2011 -- Zhejiang Jolly Pharmaceutical completed its ChiNext IPO, raising 470 million RMB ($71.5 million). The company issued 20 million shares at 23.5 RMB ($3.57) per share, a price-earnings ratio of 61. The offering was well-received and traded higher in the opening market, rising 20% to 28.18 RMB ($4.29). More details....
Stock Symbol: (SHE: 300181)
